MetaCap

Who Owns X4 Pharmaceuticals Stock?

NASDAQ: XFORHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

3.00+0.04 (+1.35%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
102.15%
Institutional holders
118
  • Institutions 99.5%
  • Insiders 0.5%
  • Public and other 0.0%

Who owns X4 Pharmaceuticals stock?

Institutional investors own about 102.2% of X4 Pharmaceuticals's shares, spread across 118 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 0.48% of XFOR.

The largest institutional holders are Morgan Stanley (11.09%), Bain Capital Life Sciences Investors, LLC (8.04%) and Perceptive Advisors Llc (8.00%). Together, the top 10 institutions control 65.9% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their XFOR positions and 4 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of XFOR

X4 Pharmaceuticals top institutional holders
InstitutionShares% HeldChange
Morgan Stanley11.00M11.09%+16.2%
Bain Capital Life Sciences Investors, LLC7.97M8.04%0.0%
Perceptive Advisors Llc7.93M8.00%+17.8%
Saturn V Capital Management LP6.97M7.03%+8.0%
Empery Asset Management, LP6.93M6.99%-22.5%
Deep Track Capital, Lp5.88M5.93%-7.3%
Blackrock Inc.5.85M5.90%+5.4%
FMR, LLC5.49M5.54%-34.0%
Kalehua Capital Management LLC3.72M3.75%0.0%
Vanguard Capital Management LLC3.56M3.59%-4.2%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of XFOR

X4 Pharmaceuticals top fund holders
FundShares% Held
Fidelity Securities Fund-Fidelity Small Cap Growth Fund3.39M3.42%
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.60M2.62%
MORGAN STANLEY INSTITUTIONAL FUND INC-Inception Portfolio2.31M2.33%
iShares Trust-iShares Russell 2000 ETF2.14M2.16%
EQ Advisors Trust-EQ/Morgan Stanley Small Cap Growth Portfolio1.82M1.83%
Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund1.69M1.70%
Fidelity Select Portfolios-Select Biotechnology Portfolio1.43M1.44%
Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund1.34M1.35%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.03M1.04%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund884.76K0.89%

Frequently asked questions

Who is the largest shareholder of X4 Pharmaceuticals?

Morgan Stanley is the largest institutional shareholder of XFOR, owning 11.09% of shares outstanding (11.00M shares) as of its latest 13F filing.

What percentage of X4 Pharmaceuticals is owned by institutions?

Institutions own about 102.2% of XFOR shares and 102.6% of the public float.

How much of X4 Pharmaceuticals do insiders own?

Insiders, such as officers and directors, own about 0.48% of XFOR shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related